U.S. Food and Drug Administration (FDA) Accepts for Priority Review Bristol Myers Squibb and bluebird bio Application for Anti-BCMA CAR T Cell Therapy Idecabtagene Vicleucel (Ide-cel, bb2121) Read more about U.S. Food and Drug Administration (FDA) Accepts for Priority Review Bristol Myers Squibb and bluebird bio Application for Anti-BCMA CAR T Cell Therapy Idecabtagene Vicleucel (Ide-cel, bb2121)
Morgan Stanley 18th Annual Global Healthcare Conference Read more about Morgan Stanley 18th Annual Global Healthcare Conference
2020 Wells Fargo Virtual Healthcare Conference Read more about 2020 Wells Fargo Virtual Healthcare Conference
bluebird bio Announces September Investor Events Read more about bluebird bio Announces September Investor Events
bluebird bio Presents New Results from Clinical Development Program of elivaldogene autotemcel (eli-cel, Lenti-D™) Gene Therapy for Cerebral Adrenoleukodystrophy (CALD), Including Updated Long-Term Data, at the 46th Annual Meeting of the EBMT Read more about bluebird bio Presents New Results from Clinical Development Program of elivaldogene autotemcel (eli-cel, Lenti-D™) Gene Therapy for Cerebral Adrenoleukodystrophy (CALD), Including Updated Long-Term Data, at the 46th Annual Meeting of the EBMT
bluebird bio to Present New Data from Clinical Studies of elivaldogene autotemcel (eli-cel, Lenti-D™) Gene Therapy for Cerebral Adrenoleukodystrophy (CALD) at the Virtual Edition of the 46th EBMT Annual Meeting Read more about bluebird bio to Present New Data from Clinical Studies of elivaldogene autotemcel (eli-cel, Lenti-D™) Gene Therapy for Cerebral Adrenoleukodystrophy (CALD) at the Virtual Edition of the 46th EBMT Annual Meeting
bluebird bio Appoints Denice Torres to Board of Directors Read more about bluebird bio Appoints Denice Torres to Board of Directors
bluebird bio Reports Second Quarter 2020 Financial Results and Recent Operational Progress Read more about bluebird bio Reports Second Quarter 2020 Financial Results and Recent Operational Progress
Canaccord Genuity 40th Annual Growth Conference Read more about Canaccord Genuity 40th Annual Growth Conference